Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease - Wikidata - awgldk - TriplyDB

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

http://www.wikidata.org/entity/Q34309107

about

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria Extracranial sources of S100B do not affect serum levels Perispinal etanercept: potential as an Alzheimer therapeutic Variant of TREM2 Associated with the Risk of Alzheimer's Disease Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice.Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease Vascular consequences of passive Abeta immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?Welcome to the Journal of Neuroinflammation!Microglia and neuroinflammation: a pathological perspective Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid.The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases Dissecting Alzheimer disease in Down syndrome using mouse models A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities Rodent models of neuroinflammation for Alzheimer's disease Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease Innate immunity in Alzheimer's disease: a complex affair Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!Interleukin-1β has trophic effects in microglia and its release is mediated by P2X7R pore.Inflammatory process in Alzheimer's Disease A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex Interferon Gamma: Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory Disease β-amyloid, microglia, and the inflammasome in Alzheimer's disease APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective Inflammation and Alzheimer's disease The zinc- and calcium-binding S100B interacts and co-localizes with IQGAP1 during dynamic rearrangement of cell membranes Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death

P2860

Q21245230-6B567F29-112D-43F1-9116-E47D4B7C0C1F Q22241536-B3764390-7B25-49DA-AA30-BAD8B964C197 Q22241758-3D03AB80-203D-4A4F-A1BC-D5AADD8B2F45 Q22250874-E2F97F02-F9B5-4E27-83FC-6C6D8DFEC769 Q22251262-8F121DDB-D126-4C3F-B558-F65D36D8AAC3 Q24315820-2CEEB32F-8C72-4B13-9A67-8982ED0F9C3C Q24316307-C582E34E-0732-496B-B840-61FEAC1D36C6 Q24622447-3C089051-330C-4184-94B0-DAE442FD6EBA Q24651822-ADBE8467-1F17-4F7D-93B3-88152BC5DB87 Q24657382-6E8A6F9B-918F-4DA2-913D-08D898ED377B Q24791744-610F5E15-D7F4-4E29-867C-264E72E467E5 Q24794327-5DF8BEFD-3684-4CDF-B890-053925B8E136 Q24799838-CF4665FE-BC28-48CA-9754-C982F1372F47 Q24803797-B3B0B719-20D7-4EC8-8407-A8B47E41ED8C Q24815721-5B85360D-1EBA-4DB9-BBD7-E39AF3EB9C16 Q26750987-D8AEB4E1-5F27-4B0C-AF3E-AE02D68BC773 Q26766681-11F9467C-094E-4FE2-B23C-531E3CD0B94C Q26766934-266B2A3A-CC4C-41E1-BB61-711D5B808920 Q26771812-460BB5A4-FA11-424F-B437-E00596399BEA Q26777254-E52023AE-84DB-4CB6-9A7B-359685E25904 Q26798983-AD768282-EBD5-43EC-A041-ECBD93A76E2B Q26822410-3D6E1212-A3FA-4F12-872B-DAF6E65D4DBB Q26824282-C3E25E90-33F3-4D5B-B7D0-32237717DD86 Q26863005-BE21AF8E-4870-435A-B76A-4CD04C65CE9F Q26864804-0C209628-296F-448E-96B3-671792B7F221 Q26864965-38F791FA-76F3-4458-A5EE-ABFA8910E693 Q26991654-6793D41F-91CA-41C0-B677-F8519D32BB58 Q27006944-839334D2-39D7-4B9B-8A34-E0FFEF545FDF Q27010652-9A63918A-C965-4B1D-B7F4-7E6646F76BF5 Q27303076-25D55509-BF51-4475-B64E-89809EE04200 Q27500412-ECC7D9ED-B8DE-4332-960F-5FECCCCC4742 Q27640155-F794E6F4-C07A-4B32-A72C-B166066DAFFB Q27928023-A3DFB739-D300-4D73-ACAA-3E05A043FFEC Q28084447-7FDED079-2E93-44D5-BA2D-0C1D4BB0FB48 Q28085213-7D3F3A74-FDAA-49CA-B623-F466FAE7FD36 Q28138617-0D6F6C24-F35D-45C3-9260-27F916493E42 Q28207354-F86A8ECC-FA73-44B6-AE30-B2962AADE09B Q28216434-5EAD28B7-6C1A-40E8-8F2C-2B149AAEE44B Q28274003-88403F0E-DF8E-4497-8F42-5540FD929676 Q28363800-01D25C04-3483-4CD7-AF66-F342C8D443BD

P2860

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

http://www.wikidata.org/entity/Q34309107

description

1989 nî lūn-bûn

@nan

1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@ast

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@en

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@nl

type

label

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@ast

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@en

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@nl

prefLabel

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@ast

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@en

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@nl

P1433

Q34309107-1A1C9FCA-1A2E-4442-9E58-3B3EC1620A31

P1476

Q34309107-B6B2D884-2405-4864-97DA-8A0A6C93EA45

P2093

Q34309107-425FA600-2786-4FEA-81CD-5428CBF8746A

Q34309107-733ED5A8-F27B-4A4A-9F40-96C2D72A83E4

Q34309107-7ACCF72D-E514-4B38-A8CA-EBBFACDE150B

Q34309107-8043360B-4559-4A7B-8290-BE2EEFB885AE

Q34309107-858C2AD2-F8A0-4A13-880D-13F7801E2BBF

Q34309107-D3FD12AA-D4F5-4C8E-93CC-78CCC7001EFA

Q34309107-EA54E0C4-7593-41AE-A529-CA048CB80E24

Q34309107-F52F0AB7-29E6-46EB-9C03-60742937B3F2

P2860

Q34309107-0EA7E60C-051B-4BBC-B872-A7E43D2F3E63

Q34309107-1D17FA9F-E38E-40B0-A930-D2756734B493

Q34309107-21F15921-88BB-4147-9005-08EDE6C5E57D

Q34309107-28E5CB98-6E54-434B-B475-79140F08223A

Q34309107-371C59AF-0039-4F2A-A158-139B00BD4575

Q34309107-3D9AED40-9E57-4BFF-AC17-2B48A1F22F5A

Q34309107-3F74CA2E-CA7B-42FE-94AE-E0F192166BE4

Q34309107-58A1758D-9DF6-4657-80A2-D7D25CDF96F8

Q34309107-5DC7A219-84CF-47BC-9EE2-951A841EC56D

Q34309107-5DF2B0A4-3E64-456D-917A-ACA58EDB1EB2

P304

Q34309107-0A62001E-4A46-4B29-A4BF-88B876D032D0

P31

Q34309107-6CB8C5F0-6400-44C7-9524-FA2D1BD3E0E4

P356

Q34309107-D875E824-2A74-4BC4-9CE8-D6BB1A664037

P407

Q34309107-55A9F706-B799-4785-AD2B-49AF1DD44892

P433

Q34309107-D0CB0CE8-825C-44C9-943C-A7A44C82A75B

P478

Q34309107-015D962A-6EA9-4E29-9A8F-C086BDFBC855

P577

Q34309107-443BCCE5-58B0-4EC4-BEE3-11B94D4B659C

P5875

Q34309107-06918482-0FA0-4518-AE1A-6F14583654CD

P698

Q34309107-71579064-7E51-4402-ADF8-291202E798A5

P921

Q34309107-3e0f7fe4-45c5-4b6a-a3d2-f12d7c2d78d0

Q34309107-77CB1C58-6CEB-4C7A-8974-CB5CFC026485

P932

Q34309107-3AC1AC39-D5CB-410F-B0E2-D6A124C3220F

P356

PNAS.86.19.7611

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Brain interleukin 1 and S-100 ...... syndrome and Alzheimer disease

@en

P2093

C Araoz

http://www.w3.org/2001/XMLSchema#string

C L White

http://www.w3.org/2001/XMLSchema#string

C Ling

http://www.w3.org/2001/XMLSchema#string

L C Stanley

http://www.w3.org/2001/XMLSchema#string

L J Perrot

http://www.w3.org/2001/XMLSchema#string

L White

http://www.w3.org/2001/XMLSchema#string

V MacLeod

http://www.w3.org/2001/XMLSchema#string

W S Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

S100ao (alpha alpha) protein is mainly located in the heart and striated muscles

Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta.

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome.

Interleukin 1 of the central nervous system is produced by ameboid microglia.

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

Are cytoplasmic microtubules heteropolymers?

P304

7611-7615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.19.7611

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20625695

http://www.w3.org/2001/XMLSchema#string

P698

2529544

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

298116

http://www.w3.org/2001/XMLSchema#string